Skip to main content

Table 2 In vitro proliferation assays with PI3K inhibitors in CT-26 and 4 T1 cell lines does not suggest in vivo efficacy by direct effect in tumor cells

From: PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity

Incucyte proliferation data IC50 (μM)

Inhibitor

Target

4 T1

CT26

Mean IC50

Mean IC50

AZD8835

PI3Kα/δ

13.913

4.591

AZD8186

PI3Kβ/δ

> 30

14.597

GDC-0941

Pan-PI3K

5.004

0.486

PI-3065

PI3Kδ

5.61

9.27